- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Invictus MD Closes Option to Acquire Las Vegas Cultivation License
Invictus MD (CSE:IMH) has announced it has closed an option agreement to acquire up to 60 percent in State of Nevada Medical Marijuana Cultivation License in Las Vegas, Nevada. As quoted in the press release: The terms of the Option allow Invictus MD to acquire 10% of the Seller within 45 days after the Seller …
Invictus MD (CSE:IMH) has announced it has closed an option agreement to acquire up to 60 percent in State of Nevada Medical Marijuana Cultivation License in Las Vegas, Nevada.
As quoted in the press release:
The terms of the Option allow Invictus MD to acquire 10% of the Seller within 45 days after the Seller has obtained its final approval for cultivation from the SNV inspection department. Invictus MD will pay the Seller $150,000 CDN in cash to secure the Option. A preliminary inspection date has been booked for late 2016 and the final cultivation license is expected to be issued in the first quarter of 2017. Upon issuance of the cultivation license, Invictus MD will have the option to acquire a 10% equity stake from the Seller (“First Option”) for $500,000 USD in cash plus $1,725,000 USD in common shares of Invictus MD at an issue price equal to the volume weighted average price (“VWAP”) for the three trading days ending on the trading day prior to the date of delivery of the option exercise notice and converted to USD using the most recent Bank of Canada noon spot rate. The Seller also grants Invictus MD the sole and exclusive option to purchase an additional 50% of the Seller for $16,875,000 USD payable in any combination of cash and/or common shares of Invictus MD. This option will expire 183 days after the closing of the First Option.
Click here to read the full press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.